Good morning :)
Switch to
Place Order

Hester Biosciences Ltd

HESTERBIO
Health CareBiotechnology
SmallcapWith a market cap of ₹1,687 cr, stock is ranked 839
Low RiskStock is 1.95x as volatile as Nifty
2,016.851.69% (+33.60)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹1,687 cr, stock is ranked 839
Low RiskStock is 1.95x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
42.896.310.50%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.474.330.91%

Forecast & RatingsDetailed Forecast 

0%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Hester Biosciences Limited is engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include Poultry Division and Large Animal Division.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+185.28+189.64+219.01+249.17+41.57+29.18+34.42+39.34
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Closure of trading window 
Announced OnSep 30, 2022

Hester Biosciences Limited has informed the Exchange about Closure of trading window | Download

Hester Biosciences Limited has informed the Exchange about Closure of trading window | Download

Press Release 
Announced OnSep 25, 2022

Hester Biosciences Limited has informed the Exchange about press release dated 25-Sep-2022 titled 20220925 Adequate supply of Goat Pox Vaccine by Hester in India to Immunize cattle against Lumpy Skin disease | Download

Hester Biosciences Limited has informed the Exchange about press release dated 25-Sep-2022 titled 20220925 Adequate supply of Goat Pox Vaccine by Hester in India to Immunize cattle against Lumpy Skin disease | Download

Cash Dividend 
Ex. DateAug 11, 2022

Final • Div/Share: ₹ 10

See all events